Drug Profile
Research programme: small molecule lipid mediators - Resolvyx Pharmaceuticals
Alternative Names: NPD 1; Resolvin D1; RvD 1; RX-05 - Resolvyx; RX-10005; RX-10008; RX-10065; RX-20001; RX-65Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Resolvyx Pharmaceuticals
- Class Omega 3 fatty acids; Small molecules
- Mechanism of Action Inflammation mediator inhibitors; Lipid modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Age-related macular degeneration; Dry eyes; Inflammation
Most Recent Events
- 04 May 2016 Discontinued - Preclinical for Age-related macular degeneration in USA (Topical)
- 04 May 2016 Discontinued - Preclinical for Dry eyes in USA (Topical)
- 04 May 2016 Discontinued - Preclinical for Inflammation in USA (unspecified route)